Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension

Naka Shiratori,1,2 Yusuke Nishio,1,2 Ayaka Takeda,1,2 Shio Sugimoto,1,2 Kenji Takazawa,2 Naomi Otsuka,3 Naruhiro Ishida,3 Daisuke Shii,3 Kiyotaka Hori,3 Kenji Nakamoto1 1Department of Ophthalmology, Nippon Medical School, Tokyo, Japan; 2Shinanozaka Clinic, Tokyo, Japan; 3Japan Medical Affairs Group,...

Full description

Saved in:
Bibliographic Details
Main Authors: Shiratori N, Nishio Y, Takeda A, Sugimoto S, Takazawa K, Otsuka N, Ishida N, Shii D, Hori K, Nakamoto K
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
omidenepag isopropyl
prostanoid ep2 agonist
24-hour iop control
Ophthalmology
RE1-994
Online Access:https://doaj.org/article/73b6835fdbf44df590df1d2a07b4f63d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/73b6835fdbf44df590df1d2a07b4f63d

Similar Items